CardioCareLive CME Courses

CardioCareLive CME Courses

Format: Online Streaming Video
Price: Free
Release Date: 8/10/17
Expiration Date: 8/10/18

EDUCATIONAL OBJECTIVES: At the conclusion of this activity, all participants should be able to:

Review the role of genetic testing and gene risk scores in lipid disorders;

Explain Familial Chylomicronemia Syndrome;

Assess the implications of ongoing lipid treatment outcomes trials for the future clinical management of patients with dyslipidemia;

Discuss strategies to improve knowledge, skills or performance of the health care team.

Format: Online Streaming Video
Price: Free
Release Date: 4/11/17
Expiration Date: 11/23/17


  • Michael J. Blaha, MD, MPH, Director of Clinical Research, Ciccarone Center for the Prevention of Heart Disease; Assistant Professor of Medicine
  • Michael Miller, MD, FACC, FAHA, Professor of Cardiovascular Medicine, Epidemiology & Public Health, University of Maryland School of Medicine
  • James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA, FASPC, is a clinical assistant professor of medicine at NYU School of Medicine
  • Marc S. Sabatine, MD, MPH, is chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group, the Lewis Dexter, MD, Distinguished Chair in Cardiovascular Medicine at Brigham and Women’s Hospital, and a professor of medicine at Harvard Medical School

Topic and Learning Objectives

  • Identify the need for effective therapies for patients with familial hypercholesterolemia
  • Assess the safety and efficacy data for trials that examined the cardiovascular impact of PCSK9 inhibitors
  • Evaluate patient groups in which treatment beyond statins may be needed to decrease lipid-related CV risk

Share This